{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:16:29Z","timestamp":1765808189121,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Associations between blood pressure (BP) with age at onset of Huntington\u2019s disease (HD) have reported inconsistent findings. We used Mendelian randomization (MR) to assess effects of BP and lowering systolic BP (SBP) via the genes encoding targets of antihypertensive drugs on age at onset of HD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Genetic variants from genome-wide association studies(GWAS) of BP traits and BP-lowering variants in genes encoding antihypertensive drugs targets were extracted. Summary statistics for age at onset of HD were retrieved from the GWAS meta-analysis of HD residual age at onset from the GEM-HD Consortium included 9064 HD patients of European ancestry (4417 males and 4,647 females). MR estimates were calculated using the inverse variance weighted method, supplemented by MR-Egger, weighted median, and MR-PRESSO methods.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Genetically predicted SBP or diastolic BP increase was associated with a later age at onset of HD. However, after SBP\/DBP was present as a covariate using multivariable MR method, no significant causal association was suggested. A 10-mm Hg reduction in SBP through variants in genes encoding targets of calcium channel blockers (CCB) was associated with an earlier age at onset of HD (\u03b2=-0.220 years, 95% CI =-0.337 to -0.102, P\u2009=\u20092.42\u2009\u00d7\u200910<jats:sup>\u2212\u20094<\/jats:sup>). We did not find a causal association between angiotensin converting enzyme inhibitors and \u03b2-blockers with the earlier HD onset. No heterogeneity and horizontal pleiotropy were identified.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This MR analysis provided evidence that genetically determined SBP lowering through antihypertensive drugs might be associated with an earlier age at onset of HD. The results may have a potential impact on management of hypertension in the pre-motor-manifest HD population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-023-02734-1","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T10:02:47Z","timestamp":1684922567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hypertension, antihypertensive drugs, and age at onset of Huntington\u2019s disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Yahui","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiongming","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2451-0254","authenticated-orcid":false,"given":"Xusheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"issue":"9557","key":"2734_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO. Huntington\u2019s disease. Lancet. 2007;369(9557):218\u201328.","journal-title":"Lancet"},{"key":"2734_CR2","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1001\/archneur.1993.00540110037003","volume":"50","author":"JF Gusella","year":"1993","unstructured":"Gusella JF, MacDonald ME, Ambrose CM, et al. Molecular genetics of Huntington\u2019s disease. Arch Neurol. 1993;50:1157\u201363.","journal-title":"Arch Neurol"},{"issue":"2","key":"2734_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","volume":"9","author":"ME Ehrlich","year":"2012","unstructured":"Ehrlich ME. Huntington\u2019s disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease. Neurotherapeutics. 2012;9(2):270\u201384.","journal-title":"Neurotherapeutics"},{"issue":"8","key":"2734_CR4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1590\/S0100-879X2006000800016","volume":"39","author":"HH Ruocco","year":"2006","unstructured":"Ruocco HH, Lopes-Cendes I, Li LM, et al. Striatal and extrastriatal atrophy in Huntington\u2019s disease and its relationship with length of the CAG repeat. Braz J Med Biol Res. 2006;39(8):1129\u201336.","journal-title":"Braz J Med Biol Res"},{"key":"2734_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fnana.2011.00055","volume":"5","author":"E Roze","year":"2011","unstructured":"Roze E, Cahill E, Martin E, et al. Huntington\u2019s Disease and Striatal Signaling. Front Neuroanat. 2011;5:55.","journal-title":"Front Neuroanat"},{"issue":"4","key":"2734_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"DR Langbehn","year":"2004","unstructured":"Langbehn DR, Brinkman RR, Falush D, et al. A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length. Clin Genet. 2004;65(4):267\u201377.","journal-title":"Clin Genet"},{"issue":"10","key":"2734_CR7","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Wexler NS, Lorimer J, Porter J, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc Natl Acad Sci U S A. 2004;101(10):3498\u2013503.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2734_CR8","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1212\/WNL.0000000000003661","volume":"88","author":"JL Schultz","year":"2017","unstructured":"Schultz JL, Kamholz JA, Moser DJ, et al. Substance abuse may hasten motor onset of Huntington disease: evaluating the Enroll-HD database. Neurology. 2017;88(9):909\u201315.","journal-title":"Neurology"},{"issue":"5","key":"2734_CR9","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.14336\/AD.2018.0911","volume":"10","author":"HL Li","year":"2019","unstructured":"Li HL, Li XY, Dong Y, et al. Clinical and genetic profiles in chinese patients with Huntington\u2019s Disease: a ten-year Multicenter Study in China. Aging Dis. 2019;10(5):1003\u201311.","journal-title":"Aging Dis"},{"issue":"10159","key":"2734_CR10","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","volume":"392","author":"GBD 2017 Risk Factor Collaborators","year":"2018","unstructured":"GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, a-nd metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of Disease Study 2017. Lance-t. 2018;392(10159):1923\u201394.","journal-title":"Lance-t"},{"issue":"4","key":"2734_CR11","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1161\/STROKEAHA.116.012949","volume":"47","author":"P Maillard","year":"2016","unstructured":"Maillard P, Mitchell GF, Himali JJ, et al. Effects of arterial stiffness on brai-n integrity in young adults from the Framingham Heart Study. Stroke. 2016;47(4):1030\u20136.","journal-title":"Stroke"},{"issue":"11","key":"2734_CR12","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1212\/WNL.0b013e3182a43e1c","volume":"81","author":"CW Tsao","year":"2013","unstructured":"Tsao CW, Seshadri S, Beiser AS, et al. Relations of arterial stiffness and en-dothelial function to brain aging in the community. Neurology. 2013;81(11):984\u201391.","journal-title":"Neurology"},{"issue":"7","key":"2734_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1212\/WNL.0000000000002368","volume":"86","author":"CW Tsao","year":"2016","unstructured":"Tsao CW, Himali JJ, Beiser AS, et al. Association of arterial stiffness with progression of subclinical brain and cognitive disease. Neurology. 2016;86(7):619\u201326.","journal-title":"Neurology"},{"key":"2734_CR14","doi-asserted-by":"publisher","first-page":"e0197975","DOI":"10.1371\/journal.pone.0197975","volume":"13","author":"L Valc\u00e1rcel-Ocete","year":"2018","unstructured":"Valc\u00e1rcel-Ocete L, Fullaondo A, Alkorta\u2010Aranburu G, et al. Does arterial hypertension influence the onset of Huntington\u2019s disease? PLoS ONE. 2018;13:e0197975.","journal-title":"PLoS ONE"},{"issue":"9","key":"2734_CR15","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1002\/mds.28062","volume":"35","author":"JL Schultz","year":"2020","unstructured":"Schultz JL, Harshman LA, Langbehn DR, Nopoulos PC. Hypertension is Associated with an earlier age of Onset of Huntington\u2019s Disease. Mov Disord. 2020;35(9):1558\u201364.","journal-title":"Mov Disord"},{"issue":"6","key":"2734_CR16","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/mds.27976","volume":"35","author":"JJ Steventon","year":"2020","unstructured":"Steventon JJ, Rosser AE, Hart E, Murphy K. Hypertension, antihypertensive use and the delayed-onset of Huntington\u2019s disease. Mov Disord. 2020;35(6):937\u201346.","journal-title":"Mov Disord"},{"key":"2734_CR17","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G. Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ (Clinical research ed). 2018;362:k601.","journal-title":"BMJ (Clinical research ed)"},{"issue":"6","key":"2734_CR18","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/ije\/dyx207","volume":"46","author":"VM Walker","year":"2017","unstructured":"Walker VM, Davey Smith G, Davies NM, Martin RM. Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities. Int J Epidemiol. 2017;46(6):2078\u201389.","journal-title":"Int J Epidemiol"},{"issue":"16","key":"2734_CR19","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of Observational Studies in Epidemiology using mendelian randomization: the STROBE-MR Statement. JAMA. 2021;326(16):1614\u201321.","journal-title":"JAMA"},{"key":"2734_CR20","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","volume":"50","author":"E Evangelou","year":"2018","unstructured":"Evangelou E, Warren HR, Mosen-Ansorena D, et al. Genetic analysis of over 1 million people identififies 535 new loci associated with blood pressure traits. Nat Genet. 2018;50:1412\u201325.","journal-title":"Nat Genet"},{"issue":"22","key":"2734_CR21","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"MA Kamat","year":"2019","unstructured":"Kamat MA, Blackshaw JA, Young R, et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019;35(22):4851\u20133.","journal-title":"Bioinformatics"},{"issue":"4","key":"2734_CR22","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/hep.32183","volume":"75","author":"L Chen","year":"2022","unstructured":"Chen L, Yang H, Li H, et al. Insights into modifiable risk factors of cholelithiasis: a mendelian randomization study. Hepatology. 2022;75(4):785\u201396.","journal-title":"Hepatology"},{"issue":"4","key":"2734_CR23","doi-asserted-by":"publisher","first-page":"e0120758","DOI":"10.1371\/journal.pone.0120758","volume":"10","author":"H Shim","year":"2015","unstructured":"Shim H, Chasman DI, Smith JD, et al. A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 Caucasians. PLoS ONE. 2015;10(4):e0120758.","journal-title":"PLoS ONE"},{"issue":"4","key":"2734_CR24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.118.038814","volume":"140","author":"D Gill","year":"2019","unstructured":"Gill D, Georgakis MK, Koskeridis F, et al. Use of genetic variants related to antihypertensive drugs to inform on efficacy and side effects. Circulation. 2019;140(4):270\u20139.","journal-title":"Circulation"},{"key":"2734_CR25","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46:D1074\u201382.","journal-title":"Nucleic Acids Res"},{"key":"2734_CR26","doi-asserted-by":"crossref","unstructured":"Fishilevich S, Nudel R, Rappaport N et al. GeneHancer: Genome-wide Integration of Enhancers and Target Genes in GeneCards. 2017. Oxford: Database; 2017.","DOI":"10.1093\/database\/bax028"},{"issue":"11","key":"2734_CR27","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/sim.6835","volume":"35","author":"S Burgess","year":"2016","unstructured":"Burgess S, Dudbridge F, Thompson SG. Combining information on multiple in strumental variables in mendelian randomization: comparison of allele score and summarized data methods. Stat Med. 2016;35(11):1880\u2013906.","journal-title":"Stat Med"},{"issue":"7","key":"2734_CR28","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/jamacardio.2018.1470","volume":"3","author":"S Burgess","year":"2018","unstructured":"Burgess S, Ference BA, Staley JR, et al. Association of LPA variants with risk of coronary disease and the implications for lipoprotein(a)-lowering therapies: a men delian randomization analysis. JAMA Cardiol. 2018;3(7):619\u201327.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"2734_CR29","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1038\/s41467-018-06467-9","volume":"9","author":"C Nowak","year":"2018","unstructured":"Nowak C, Arnlov J. A mendelian randomization study of the effffects of blood lipids on breast cancer risk. Nat Commun. 2018;9(1):3957.","journal-title":"Nat Commun"},{"issue":"4","key":"2734_CR30","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cell.2019.06.036","volume":"178","author":"Genetic Modififiers of Huntington\u2019s Disease (GeM-HD) Consortium","year":"2019","unstructured":"Genetic Modififiers of Huntington\u2019s Disease (GeM-HD) Consortium. CAG repeat not polyglutamine length determines timing of huntington\u2019s disease onset. Cell. 2019;178(4):887\u2013900.","journal-title":"Cell"},{"issue":"5","key":"2734_CR31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377\u201389.","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"2734_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some Invalid Instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314.","journal-title":"Genet Epidemiol"},{"issue":"5","key":"2734_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet"},{"issue":"21","key":"2734_CR34","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/sim.6522","volume":"34","author":"MF Greco","year":"2015","unstructured":"Greco MF, Minelli C, Sheehan NA, Thompson JR. Detecting pleiotropy in mendelian randomisation studies with summary data and a continuous outcome. Stat Med. 2015;34(21):2926\u201340.","journal-title":"Stat Med"},{"issue":"11","key":"2734_CR35","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.1016\/j.clnu.2021.09.041","volume":"40","author":"M Wang","year":"2021","unstructured":"Wang M, Cornelis MC, Zhang Z, et al. Mendelian randomization study of coffee consumption and age at onset of Huntington\u2019s disease. Clin Nutr. 2021;40(11):5615\u20138.","journal-title":"Clin Nutr"},{"key":"2734_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.parkreldis.2022.02.013","volume":"97","author":"M Wang","year":"2022","unstructured":"Wang M, Liu D, Yang S, et al. Smoking, alcohol consumption, and age at onset of Huntington\u2019s disease: a mendelian randomization study. Parkinsonism Relat Disord. 2022;97:34\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"2734_CR37","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s00415-018-8972-y","volume":"265","author":"NA Aziz","year":"2018","unstructured":"Aziz NA, Weydt P. Telomere length as a modifier of age-at-onset in Huntington disease: a two-sample mendelian randomization study. J Neurol. 2018;265(9):2149\u201351.","journal-title":"J Neurol"},{"issue":"1","key":"2734_CR38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neurobiolaging.2013.06.011","volume":"35","author":"L Glodzik","year":"2014","unstructured":"Glodzik L, Rusinek H, Pirraglia E, et al. Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly. Neurobiol Aging. 2014;35(1):64\u201371.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"2734_CR39","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/ajh.2009.20","volume":"22","author":"AR Zazulia","year":"2009","unstructured":"Zazulia AR. Regulation of cerebral blood flow in untreated mild-to-moderate hypertension. Am J Hypertens. 2009;22(4):344.","journal-title":"Am J Hypertens"},{"issue":"6","key":"2734_CR40","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/jcbfm.2008.13","volume":"28","author":"AH van Beek","year":"2008","unstructured":"van Beek AH, Claassen JA, Rikkert MG, et al. Cerebral autoregulation: a overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab. 2008;28(6):1071\u201385.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"2734_CR41","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2353\/ajpath.2010.090750","volume":"177","author":"MA Koike","year":"2010","unstructured":"Koike MA, Green KN, Blurton-Jones M, et al. Oligemic hypoperfusion differentially affects tau and amyloid-{beta}. Am J Pathol. 2010;177(1):300\u201310.","journal-title":"Am J Pathol"},{"issue":"5849","key":"2734_CR42","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1126\/science.318.5849.384","volume":"318","author":"J Marx","year":"2007","unstructured":"Marx J. Alzheimer\u2019s disease. JM Fresh evidence points to an old suspect: calcium. Science. 2007;318(5849):384\u20135.","journal-title":"Science"},{"issue":"1","key":"2734_CR43","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1038\/s41467-019-09494-2","volume":"10","author":"FH Siddiqi","year":"2019","unstructured":"Siddiqi FH, Menzies FM, Lopez A, et al. Felodipine induces autophagy in mouse brains with pharmacokinetics amenable to repurposing. Nat Commun. 2019;10(1):1817.","journal-title":"Nat Commun"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02734-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02734-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02734-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T10:15:00Z","timestamp":1684923300000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02734-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2734"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02734-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2023,5,24]]},"assertion":[{"value":"24 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since all analyses were performed using publicly available genome-wide association study (GWAS) summary data that had already obtained ethical review board approvals, no additional ethical permission was required from our institutional research ethics committees.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}